(GLUT2) Inhibitors - ACS Publications - American Chemical Society

6 days ago - EA-3, MOA, and MOB) met this specification (Table 1), their. GLUT2 specificity was confirmed using 2-deoxyglucose, which is only transpor...
0 downloads 11 Views 1MB Size
Subscriber access provided by - Access paid by the | UCSB Libraries

Bioactive Constituents, Metabolites, and Functions

Homoisoflavonoids are potent glucose transporter 2 (GLUT 2) inhibitors – a potential mechanism for the glucose-lowering properties of Polygonatum odoratum Huijun Wang, Mark Fowler, David Messenge, Leon A. Terry, Xuelan Gu, Luxian Zhou, Ruimin Liu, Juan Su, Songshan Shi, José Ordaz-Ortiz, Guoping Lian, Mark Berry, and Shunchun Wang J. Agric. Food Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jafc.8b00107 • Publication Date (Web): 13 Mar 2018 Downloaded from http://pubs.acs.org on March 13, 2018

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 33

Journal of Agricultural and Food Chemistry

1

Homoisoflavonoids are potent glucose transporter 2 (GLUT 2) inhibitors – a

2

potential mechanism for the glucose-lowering properties of Polygonatum odoratum †,‡,∇ ,

Mark I. Fowler ‡, David J. Messenger ‡, Leon A. Terry §, Xuelan Gu ║, Luxian

3

Huijun Wang

4

Zhou ║, Ruimin Liu †, Juan Su†, Songshan Shi †, José Juan Ordaz-Ortiz O, Guoping Lian ‡, Mark J.

5

Berry *,‡, Shunchun Wang *,†

6



The MOE Key Laboratory for Standardization of Chinese Medicines and the SATCM Key

7

Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese

8

Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road,

9

Shanghai 201203, P. R. China;

10



Unilever R&D Colworth, Colworth Science Park, Sharnbrook, Bedford MK44 1LQ, U.K.;

11

§

Plant Science Laboratory, Cranfield University, MK43 0AL, U.K.;

12



Unilever R&D Shanghai, 5/F, 66 Lin Xin Road, Shanghai 200335, P. R. China;

13



Central Research Institute, Shanghai Pharmaceuticals Holding Co., Ltd., Building 4, 898 Halei Road, Shanghai 201203, P. R. China;

14

15 16

O

National Laboratory of Genomics for Biodiversity, CINVESTAV IPN, 36824 Irapuato, Guanajuato, Mexico.

17

CORRESPONDING AUTHORS

18

* Mark J. Berry, Unilever R&D Colworth, Colworth Science Park, Sharnbrook, Bedford MK44 1LQ,

19

U.K. Tel.: +44 1234222180; E-Mail: [email protected] ; ORCID: 0000-0002-6211-6151

20

* Shunchun Wang, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese

21

Medicine, 1200 Cailun Road, Shanghai 201203, P. R. China; Tel.: +86-21-5132-2511; Fax:

22

+86-21-5132-2519; E-Mail: [email protected] ; ORCID: 0000-0003-0384-1350 1

ACS Paragon Plus Environment

Journal of Agricultural and Food Chemistry

23

ABSTRACT

24

Foods of high carbohydrate content such as sucrose or starch increase postprandial blood glucose

25

concentrations. The glucose absorption system in the intestine comprises two components:

26

sodium-dependent glucose transporter-1 (SGLT1) and glucose transporter 2 (GLUT2). Here five

27

sappanin-type (SAP) homoisoflavonoids were identified as novel potent GLUT2 inhibitors, with

28

three of them isolated from the fibrous roots of Polygonatum odoratum (Mill.) Druce. SAP

29

homoisolflavonoids had a stronger inhibitory effect on 25 mM glucose transport (41.6±2.5%,

30

50.5±7.6%, 47.5±1.9%, 42.6±2.4%, and 45.7±4.1% for EA-1, EA-2, EA-3, MOA, and MOB) than

31

flavonoids (19.3±2.2%, 11.5±3.7%, 16.4±2.4%, 5.3±1.0%, 3.7±2.2%, and 18.1±2.4% for apigenin,

32

luteolin, quercetin, naringenin, hesperetin, and genistein) and phloretin (28.1±1.6%) at 15 mM. SAP

33

homoisoflavonoids and SGLT1 inhibitors were found to synergistically inhibit the uptake of glucose

34

using an in vitro model comprising Caco-2 cells. This observed new mechanism of the

35

glucose-lowering action of P. odoratum suggests that SAP homoisoflavonoids and their combination

36

with flavonoid monoglucosides show promise as naturally functional ingredients for inclusion in

37

foods and drinks designed to control post-prandial glucose levels.

38

KEYWORDS: Polygonatum odoratum, homoisoflavonoids, GLUT2 inhibitors, synergy, glucose

39

control

40 41

2

ACS Paragon Plus Environment

Page 2 of 33

Page 3 of 33

Journal of Agricultural and Food Chemistry

42

 INTRODUCTION

43

As a very common chronic disease, diabetes is becoming one of the greatest global health burdens

44

along with cancer, cardiovascular and cerebrovascular diseases because of its high prevalence,

45

morbidity and mortality1. The prevalence of diabetes for all adults worldwide was estimated to be

46

415 million in 2015 and this number is expected to increase to ca. 642 million by 20402-42-4. Diabetes

47

is characterized by hyperglycemia resulting from a defect in insulin secretion, insulin action, or both5.

48

Consumption of foods high in available carbohydrate such as sucrose or starch increases postprandial

49

blood glucose concentrations6. It has been reported that an elevated postprandial glucose level is

50

associated with the development of diabetes. Node et al.2 reported high post-prandial plasma glucose

51

‘‘spikes’’ are associated with an increased risk of developing type 2 diabetes. Controlling the

52

post-meal glucose level is known to be important in both diabetic patients as well as normal healthy

53

subjects7, 8. Unregulated glycemic excursions are undesirable, and any reduction or ‘‘blunting’’ of the

54

post-prandial glucose concentration in blood is potentially beneficial.

55

The glucose absorption system in the intestine comprises two components. One is a

56

well-established component mediated by the apically located, sodium-dependent glucose

57

transporter-1 (SGLT1), a high-affinity, low-capacity, active transport protein. The other component is

58

glucose transporter 2 (GLUT2), a low-affinity, high-capacity, facilitated transport protein9, 10. Kellett

59

et al.11 described the potential interplay of these transporters during the consumption of a

60

carbohydrate rich meal. We have illustrated this interplay schematically in Figure S1. Before the

61

meal, the concentration of free glucose in the lumen of the intestine is low (